Lyon BJI Cohort Study
Status
Conditions
Details and patient eligibility
About
The prospective Cohort includes all patients with bone or joint infection (BJI), with or without implant. The aim of this Cohort is to improve the knowledges about the treatment failure and the occurrence of serious adverse events. Various data of patients included are collected and will be analysed.
Patients with a bone or joint infection are treated at the department of infectious diseases, at Infectious disease department of Hospices Civils de Lyon. They have regularly a consultation with a physician: 2-3 weeks after surgery, 6 weeks after surgery, 3 months after surgery, 6 months after surgery, 12 months after surgery and 24 months after surgery. It allows to the physician to follow the evolution of the patient under treatment and after discontinuation of the treatment.
Several data are collected during the follow-up concerning: demographics data, treatment including the use of off-label antibiotics for the treatment of BJI, adverse events, microbiology, surgeries, healing or relapse, date of symptoms, ASA score, implant or not. If there is an implant, the date of implantation and the number of the prosthesis infected are collected.
This cohort allows to improve knowledge concerning the treatment failure and the occurrence of adverse events.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
- patients with bone or joint infection, with or without implant
Trial contacts and locations
Loading...
Central trial contact
Tristan Ferry, MD, PhD; Eugénie Mabrut, ARC
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal